Palliative Radiotherapy Protocol in Head and Neck Cancer
Phase II prospective study or Palliative Radiotherapy of 25 Gy in 5 fractions, Intensity Modulated, for frail patients with incurable head and neck cancer. Comprehensive Quality of life (QLQ-C30, head and neck module, QLQ C15 PAL) and toxicity data (CTCAE v 4.0) collected.
Head and Neck Neoplasms|Quality of Life
RADIATION: palliative radiation therapy
Quality of life, EORTC QLQ-C30 questionnaire (QLQ-C15-PAL and H\&N35 modules), from radiation treatment until 24 months planned follow-up or death
Toxicity (CTCAE v 4.0 graded), CTCAE v 4.0 graded toxicities, from radiation treatment until 24 months planned follow-up or death
Progression free survival, from radiation treatment until 24 months planned follow-up or progression or death|Overall survival, from radiation treatment until 24 months planned follow-up or death
Patients deemed too frail for radical treatment or incurable because of tumour extension, as determined by an experienced tumour board, were eligible for this study of palliative radiotherapy delivered by intensity modulation, 25 Gy in 5 daily fractions over one week. This study was conducted in two academic centers.